1. Home
  2. CCSI vs STRO Comparison

CCSI vs STRO Comparison

Compare CCSI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consensus Cloud Solutions Inc.

CCSI

Consensus Cloud Solutions Inc.

HOLD

Current Price

$35.03

Market Cap

493.6M

Sector

Technology

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$29.55

Market Cap

491.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCSI
STRO
Founded
2021
2003
Country
United States
United States
Employees
N/A
133
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
493.6M
491.0M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
CCSI
STRO
Price
$35.03
$29.55
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$37.50
$31.33
AVG Volume (30 Days)
144.7K
252.3K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.30
N/A
Revenue
$349,696,000.00
N/A
Revenue This Year
$3.33
N/A
Revenue Next Year
$2.70
N/A
P/E Ratio
$27.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.42
$0.67
52 Week High
$37.30
$43.85

Technical Indicators

Market Signals
Indicator
CCSI
STRO
Relative Strength Index (RSI) 60.69 51.94
Support Level $25.76 $23.53
Resistance Level $36.36 $30.94
Average True Range (ATR) 1.62 2.69
MACD -0.18 0.51
Stochastic Oscillator 75.67 70.12

Price Performance

Historical Comparison
CCSI
STRO

About CCSI Consensus Cloud Solutions Inc.

Consensus Cloud Solutions Inc is a provider of secure information delivery services with a scalable Software-as-a-Service SaaS platform. It is engaged in the fax cloud business. The company's offerings include communication, data extraction, and digital signature solutions that enable users to securely access, exchange, and manage information across organizational and geographic boundaries. It serves multiple industry verticals, including healthcare, government, financial services, legal, and education. Geographically, the company operates in the United States, Canada, Ireland, and other countries. It derives the maximum revenue from the United States.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: